The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease
Victor L. Serebruany, Motoji Kogushi, Daniela Dastros-Pitei, Marcus Flather, Deepak L. Bhatt
Dive into the research topics of 'The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease'. Together they form a unique fingerprint.